Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 trial evaluating long-term treatment with bimekizumab in adults with moderate to severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 trial evaluating subcutaneous sonelokimab versus placebo in adults with moderate to severe hidradenitis suppurativa has been complet…
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 long-term study evaluating bimekizumab in participants with moderate to severe hidradenitis suppurativa is currently active but not …
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 clinical trial update for long-term use of bimekizumab in moderate to severe hidradenitis suppurativa.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab [Phase 2, Phase 3]
Phase 2/3 trial evaluating long-term treatment with spesolimab in hidradenitis suppurativa (HS); the study has been terminated with results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 trial evaluating subcutaneous sonelokimab vs placebo in adults with moderate to severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2026-06-08Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 trial evaluating subcutaneous sonelokimab vs placebo in adults with moderate to severe hidradenitis suppurativa has been completed.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 study evaluating the efficacy, safety, and tolerability of remibrutinib in adults and adolescents with moderate to severe hidraden…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 long-term study evaluating bimekizumab in participants with moderate to severe hidradenitis suppurativa is active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of lutikizumab in adults and adolescents with moderate to severe hidradenitis supp…
-
CLINICAL_TRIALS trial_result · 2026-04-28Clinical Trial Results: Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment [Phase 2]
Phase 2 trial results for topical ruxolitinib 1.5% in hidradenitis suppurativa have been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Aviclear for Hidradenitis Suppurativa (HS) [NA]
Aviclear for hidradenitis suppurativa is listed as an active but not recruiting clinical trial, sponsored by the University of Miami.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating the efficacy and safety of AVTX-009 in moderate to severe hidradenitis suppurativa has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 4]
A Phase 4 clinical trial is planned to evaluate the efficacy and safety of secukinumab in Chinese adults with moderate-to-severe hidradeniti…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib [Phase 3]
This clinical trial update notes a rollover study for participants previously enrolled in povorcitinib trials for hidradenitis suppurativa, …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Clinical trial update on the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidra…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa [Phase 1]
This clinical trial update indicates a Phase 1 study to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants w…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
It is a Phase 3 study assessing the long-term safety and efficacy of povorcitinib in participants with moderate-to-severe hidradenitis suppu…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Adalimumab (AVT-02) Across Multiple Indications.
Clinical trial update evaluating injection site pain and adherence when switching from a low to high concentration AVT-02 (adalimumab) acros…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
Ongoing Phase 3 trial update examining long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in adults with moderate to s…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Bioelectric Dressing for Post De-Roofing Treatment of HS [NA]
A completed clinical trial evaluated a bioelectric dressing as a post-de-roofing treatment for hidradenitis suppurativa. Results have been p…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.
The clinical trial evaluating an AI diagnostic tool for primary care doctors assessing skin conditions has been completed. The study evaluat…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 study evaluating the efficacy and safety of povorcitinib (INCB054707) in adults with moderate-to-severe hidradenitis suppurativa h…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 trial evaluating the efficacy and safety of investigational treatments for moderate to severe hidradenitis suppurativa; the study is…